Raphaël Ognar, MBA, MSc

Springfield, New Jersey, United States
Pharma/Biotech executive with over 25 years expertise of throughout the whole product lifecycle steps, obtained from an extensive experience in Oncology/Hematology and leadership skills through multiple country and global roles. For the last decade, he increased his focus on Immuno-Oncology and Cell Therapy technologies.
In 2018 he created ANIM8 LLC, to provided strategy and operations support to early-stage biotech and RWE/DHS companies.
July 2021, he founded NKILT Therapeutics to build, with his co-founders, a novel & disruptive allogeneic cell therapy technology.
March 2022, he joined Alira Health's leadership to expand their C> & IO capabilities.
Besides fighting cancer, his passions are vintage wines, playing music, pushing himself rock climbing and traveling the world with family and friends.
Raphaël owns Masters & D.E.A. of Physiology/Neurosciences from University of Bordeaux I&II, and an MBA in Strategic Marketing & Enterprise Management from I.A.E of Tours University.
Speaking In
9:45 AM - 10:00 AM (EST)
Tuesday, February 7
NKILT Therapeutics is a new cell therapy biotech developing a novel approach of engineering Natural…